by Raynovich Rod | Nov 27, 2018 | Biopharmaceuticals
Update-2 December 3 …Our Top Pick TSRO is up 58% on GSK Buyout We recommended Tesaro (TSRO) at $34 and it paid off today with a ~$5.1B buyout by GlaxoSmith Kline! Year End Rally Intact with XBI up over 3% to $84 handle, ====== Update-1 December 1… NASDAQ...
by Raynovich Rod | Nov 19, 2018 | Biopharmaceuticals
Update for the Week: Trying to Find the Bottom-Choppy Action But Tradeable XBI holds above $74.62 bottom up 1.3% for the week but can’t hold today’s gains. AMGN flat for the week at $193 but can’t hold gains at mid-week. Big winner TSRO up 64.9% for...
by Raynovich Rod | Nov 12, 2018 | Biopharmaceuticals
11/16…TSRO Alert at $35, Up 32%, Company is for Sale 11/15p After Close…Traders: Rally is intact but needs another green day to confirm. Big mid-cap 4% movers today: AGIO ARNA (up 21.6%) ARRY CRSP LOXO NBIX ICPT SRPT XNCR We added small positions over the...
by Raynovich Rod | Nov 4, 2018 | 2023 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update at Close 11/9/18 Remain Cautious as Rally Fails The NASDAQ down 1.6% and Russell 2000 down 1.8%, sold off killing hopes of a continued Post-Election rally. The biotech sector is for experienced traders only. The healthcare still looks good overall with the XLV...